AstraZeneca blood cancer drug Calquence meets primary goal in late-stage trial Medical Dialogues Bureau9 Jun 2019 9:10 AM ISTThe drug, Calquence, is a cornerstone product for AstraZeneca in haematology and its accelerated U.S. approval in 2017 marked its first entry into...
Tighter EU rules could trigger antibiotic shortage; says Fresenius Medical Dialogues Bureau9 Jun 2019 9:00 AM ISTFresenius said that under the draft proposals, the bulk-freeze-dryers that is used to produce the antibiotic would have to be sterilised more...
Over Rs 74 crore fine on Himalaya, Intas Pharma, 2 Chemist Associations for anti-competitive trade practices Medical Dialogues Bureau8 Jun 2019 2:35 PM ISTAs per the CCI order, Himalaya Drug was fined Rs 18.59 crore while its three senior officials were fined a total of nearly Rs 4 lakh. Besides, Intas...
Caught On Camera: Chemist being thrashed by Politician for not welcoming him Farhat Nasim8 Jun 2019 12:55 PM ISTBihar: Misuse of political clout has come to the fore as a brother of a former Bihar minister and BJP national vice president was recently caught on...
GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma Medical Dialogues Bureau8 Jun 2019 10:00 AM ISTThe price tag for the mainly Europe-focused brand portfolio, which includes itch relief cream Eurax, antiseptic cream Savlon and Tixylix cough...
Aurobindo Pharma, subsidiary made party to litigation proceedings in US Medical Dialogues Bureau8 Jun 2019 9:45 AM ISTThe company was reacting to a media report as per which, bankrupt US drug firm Aceto Corporation has accused Aurobindo Pharma and its founder P V...
Sanofi poised to appoint Novartis' Paul Hudson as CEO Medical Dialogues Bureau8 Jun 2019 9:44 AM ISTPARIS: Sanofi is poised to appoint Paul Hudson, a top executive with Switzerland's Novartis, to become the French drugmaker's next CEO from Sept. 1, a...
Opioid maker agrees to pay $225 million to settle federal probes Medical Dialogues Bureau8 Jun 2019 9:00 AM ISTWASHINGTON: An opioid manufacturer has agreed to pay $225 million to resolve federal investigations into allegations that it paid kickbacks and used...
Fighting TB battle: FDA advisory panel recommends approval of TB Alliance's tuberculosis treatment Medical Dialogues Bureau7 Jun 2019 2:53 PM ISTIndependent experts of an FDA advisory panel voted in favour of the not-for-profit TB Alliance's treatment for drug-resistant tuberculosis, as a part...
Alembic Pharma gets USFDA nod for Carbidopa and Levodopa extended-release tablets for Parkinson's treatment Medical Dialogues Bureau7 Jun 2019 2:23 PM ISTNew Delhi: Alembic Pharmaceuticals on Thursday informed it has received approval from the US health regulator for Carbidopa and Levodopa...
Natco Pharma- Kothur facility gets 9 observations from USFDA Medical Dialogues Bureau7 Jun 2019 2:21 PM ISTNEW DELHI: Natco Pharma Thursday said the US health regulator has made nine observations after the completion of inspection of its Kothur formulation...
Marksans Pharma gets EIR from USFDA for its Goa facility Medical Dialogues Bureau7 Jun 2019 2:20 PM ISTNew Delhi: Drug firm Marksans Pharma Thursday said it has received Establishment Inspection Report (EIR) from the US health regulator for its Goa...
